Seth P Lerner

13PUBLICATIONS
93CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Narrative Review of Potential Non-Surgical Treatments for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer.

|Nov 18, 2025
Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World Data.

Sarmad Sadeghi, Primo N Lara, Andrea Necchi

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Sep 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies.

Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess

|Nov 05, 2024
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial.

Gopa Iyer, Catherine M Tangen, Michal Sarfaty

|Sep 10, 2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma.

Pedro Barata, Catherine Tangen, Melissa Plets

Pageof 3

Frequent Collaborators

3 joint publications

Siamak Daneshmand

3 joint publications

Thomas W Flaig

3 joint publications

Catherine Tangen

3 joint publications

Andrea B Apolo